Skip to main content
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Registry for Patients Taking Uptravi (SPHERE)

view all Clinical Trials

Overview

This is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi. Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry.

Contact

For more information about this trial or to inquire about eligibility, email breathe@temple.edu